Cardiac Risk-Informed Treatment of EGFR-Mutant Lung Cancer With Osimertinib

por Piper-Vallillo, Andrew J., Sequist, Lecia V.
Publicado 2019

Revolving Door of Histologic Transformation—Tumor Heterogeneity Complicating the Management of EGFR-Mutated Lung Adenocarcinoma: A Case of Jekyll and Hyde

por Wysota, Michael, Asiry, Saeed, Goldstein, Yitzhak, Sequist, Lecia V., Khader, Samer, Halmos, Balazs
Publicado 2020

Can CT radiomic analysis in NSCLC predict histology and EGFR mutation status?

por Digumarthy, Subba R., Padole, Atul M., Gullo, Roberto Lo, Sequist, Lecia V., Kalra, Mannudeep K.
Publicado 2019

Diffuse Lung Metastases in EGFR-Mutant Non-Small Cell Lung Cancer

por Digumarthy, Subba R., Mendoza, Dexter P., Padole, Atul, Chen, Tianqi, Peterson, P. Gabriel, Piotrowska, Zofia, Sequist, Lecia V.
Publicado 2019

Predicting malignant potential of subsolid nodules: can radiomics preempt longitudinal follow up CT?

por Digumarthy, Subba R., Padole, Atul M., Rastogi, Shivam, Price, Melissa, Mooradian, Meghan J., Sequist, Lecia V., Kalra, Mannudeep K.
Publicado 2019

Osimertinib for Previously Treated Patients With Advanced EGFR T790M Mutation-Positive NSCLC: Tolerability and Diagnostic Methods From an Expanded Access Program

por Santos, Edgardo S., Kaplan, Barry, Kirshner, Eli, Croft, Elisabeth F., Sequist, Lecia V., Chau, MyDoanh, Munley, Jiefen, Oxnard, Geoffrey R.
Publicado 2018

Incidence of Radiation Therapy Among Patients Enrolled in a Multidisciplinary Pulmonary Nodule and Lung Cancer Screening Clinic

por Milligan, Michael G., Lennes, Inga T., Hawari, Saif, Khandekar, Melin J., Colson, Yolonda, Shepard, Jo-Anne O., Frank, Angela, Sequist, Lecia V., Willers, Henning, Keane, Florence K.
Publicado 2022

Phase II Study of Cabozantinib in Patients With Bone Metastasis

por Choy, Edwin, Cote, Gregory M, Michaelson, M Dror, Wirth, Lori, Gainor, Justin F, Muzikansky, Alona, Sequist, Lecia V, Sullivan, Ryan J, Fidias, Panagiotis M, Shaw, Alice, Heist, Rebecca S
Publicado 2022

Clinicopathologic Characteristics and Outcomes for Patients With KRAS G12D-Mutant NSCLC

por Cooper, Alissa J., Muzikansky, Alona, Lennerz, Jochen, Narinesingh, Farhaana, Mino-Kenudson, Mari, Hung, Yin P., Piotrowska, Zofia, Dagogo-Jack, Ibiayi, Sequist, Lecia V., Gainor, Justin F., Lin, Jessica J., Heist, Rebecca S.
Publicado 2022

Role of sex in lung cancer risk prediction based on single low-dose chest computed tomography

por Simon, Judit, Mikhael, Peter, Tahir, Ismail, Graur, Alexander, Ringer, Stefan, Fata, Amanda, Jeffrey, Yang Chi-Fu, Shepard, Jo-Anne, Jacobson, Francine, Barzilay, Regina, Sequist, Lecia V., Pace, Lydia E., Fintelmann, Florian J.
Publicado 2023

Acquired Resistance of EGFR-Mutated Lung Cancer to Tyrosine Kinase Inhibitor Treatment Promotes PARP Inhibitor Sensitivity

por Marcar, Lynnette, Bardhan, Kankana, Gheorghiu, Liliana, Dinkelborg, Patrick, Pfäffle, Heike, Liu, Qi, Wang, Meng, Piotrowska, Zofia, Sequist, Lecia V., Borgmann, Kerstin, Settleman, Jeffrey E., Engelman, Jeffrey A., Hata, Aaron N., Willers, Henning
Publicado 2019

Efficacy and Tolerability of ALK/MET Combinations in Patients With ALK-Rearranged Lung Cancer With Acquired MET Amplification: A Retrospective Analysis

por Dagogo-Jack, Ibiayi, Kiedrowski, Lesli A., Heist, Rebecca S., Lin, Jessica J., Meador, Catherine B., Krueger, Elizabeth A., Do, Andrew, Peterson, Jennifer, Sequist, Lecia V., Gainor, Justin F., Lennerz, Jochen K., Digumarthy, Subba R.
Publicado 2023

B-Cell Infiltrate in the Tumor Microenvironment Is Associated With Improved Survival in Resected Lung Adenocarcinoma

por Dagogo-Jack, Ibiayi, Valiev, Ivan, Kotlov, Nikita, Belozerova, Anna, Lopareva, Aleksandra, Butusova, Anna, Samarina, Naira, Boyko, Alexandra, Xiang, Zhongmin, Johnson, Monique, Degryse, Sandrine, Keane, Florence K., Sequist, Lecia V., Lanuti, Michael, Fowler, Nathan, Mino-Kenudson, Mari, Bagaev, Alexander
Publicado 2023

Safety and Success of Repeat Lung Needle Biopsies in Patients with Epidermal Growth Factor Receptor‐Mutant Lung Cancer

por Fintelmann, Florian J., Troschel, Fabian M., Kuklinski, Martin W., McDermott, Shaunagh, Petranovic, Milena, Digumarthy, Subba R., Sharma, Amita, Troschel, Amelie S., Price, Melissa C., Hariri, Lida P., Gilman, Matthew D., Shepard, Joanne O., Sequist, Lecia V., Piotrowska, Zofia
Publicado 2019

EGFR mutation detection in circulating cell-free DNA of lung adenocarcinoma patients: analysis of LUX-Lung 3 and 6

por Wu, Yi-Long, Sequist, Lecia V, Hu, Cheng-Ping, Feng, Jifeng, Lu, Shun, Huang, Yunchao, Li, Wei, Hou, Mei, Schuler, Martin, Mok, Tony, Yamamoto, Nobuyuki, O'Byrne, Kenneth, Hirsh, Vera, Gibson, Neil, Massey, Dan, Kim, Miyoung, Yang, James Chih-Hsin
Publicado 2017

Does EGFR Mutation Type Influence Patient-Reported Outcomes in Patients with Advanced EGFR Mutation-Positive Non-Small-Cell Lung Cancer? Analysis of Two Large, Phase III Studies Co...

por Wu, Yi-Long, Hirsh, Vera, Sequist, Lecia V., Hu, Cheng-Ping, Feng, Jifeng, Lu, Shun, Huang, Yunchao, Schuler, Martin, Mok, Tony, Yamamoto, Nobuyuki, O’Byrne, Kenneth, Geater, Sarayut L., Zhou, Caicun, Massey, Dan, Märten, Angela, Lungershausen, Juliane, Yang, James Chih-Hsin
Publicado 2017

Sybil: A Validated Deep Learning Model to Predict Future Lung Cancer Risk From a Single Low-Dose Chest Computed Tomography

por Mikhael, Peter G., Wohlwend, Jeremy, Yala, Adam, Karstens, Ludvig, Xiang, Justin, Takigami, Angelo K., Bourgouin, Patrick P., Chan, PuiYee, Mrah, Sofiane, Amayri, Wael, Juan, Yu-Hsiang, Yang, Cheng-Ta, Wan, Yung-Liang, Lin, Gigin, Sequist, Lecia V., Fintelmann, Florian J., Barzilay, Regina
Publicado 2023

High-Dose Osimertinib for CNS Progression in EGFR+ NSCLC: A Multi-Institutional Experience

por Piper-Vallillo, A.J., Rotow, Julia K., Aredo, Jacqueline V., Shaverdashvili, Khvaramze, Luo, Jia, Carlisle, Jennifer W., Husain, Hatim, Muzikansky, Alona, Heist, Rebecca S., Rangachari, Deepa, Ramalingam, Suresh S., Wakelee, Heather A., Yu, Helena A., Sequist, Lecia V., Bauml, Joshua M., Neal, Joel W., Piotrowska, Zofia
Publicado 2022

Monolithic Chip for High-throughput Blood Cell Depletion to Sort Rare Circulating Tumor Cells

por Fachin, Fabio, Spuhler, Philipp, Martel-Foley, Joseph M., Edd, Jon F., Barber, Thomas A., Walsh, John, Karabacak, Murat, Pai, Vincent, Yu, Melissa, Smith, Kyle, Hwang, Henry, Yang, Jennifer, Shah, Sahil, Yarmush, Ruby, Sequist, Lecia V., Stott, Shannon L., Maheswaran, Shyamala, Haber, Daniel A., Kapur, Ravi, Toner, Mehmet
Publicado 2017

Engineered nanointerfaces for microfluidic isolation and molecular profiling of tumor-specific extracellular vesicles

por Reátegui, Eduardo, van der Vos, Kristan E., Lai, Charles P., Zeinali, Mahnaz, Atai, Nadia A., Aldikacti, Berent, Floyd, Frederick P., H. Khankhel, Aimal, Thapar, Vishal, Hochberg, Fred H., Sequist, Lecia V., Nahed, Brian V., S. Carter, Bob, Toner, Mehmet, Balaj, Leonora, T. Ting, David, Breakefield, Xandra O., Stott, Shannon L.
Publicado 2018